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.2013.02.Abstract Background: Lidocaine attenuates the stress response to surgery when given intrave-
nously. This study investigated the effect of perioperative lidocaine infusion on hormonal responses,
bowel function and hospital stay after major abdominal surgeries in pediatrics.
Methods: After obtaining the Research Ethics Board (REB) approval and written informed parental
consent, 80 pediatric patients aged 1–6 years, ASA II, III scheduled for abdominal major surgery
were randomly allocated into two groups, each of forty children. Twenty minutes before induction,
children in placebo group received saline in a rate of 1.5 ml/kg/h and those in lidocaine group received
lidocaine 1.5 mg/kg intravenously then infusion of 1.5 mg/kg/h up to 6 h postoperatively. Length of
hospital stay and return of bowel function were reported. Plasma cortisol was recorded at baseline,
10 min after continuous infusion, 5 min after intubation and 10 min after extubation. Serum lido-
caine concentrations were recorded 10 min after start of infusion, 10 min and 4 h after extubation.
Results: Patients in placebo group showed signiﬁcant higher plasma cortisol concentrations
(P= 0.001) in response to induction of anesthesia and extended postoperatively when compared
to lidocaine group.partment of Anesthesiology,
niversity, Samia Elgamal,
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226 A. El-Deeb et al.Hospital stay was signiﬁcantly less in lidocaine group (5 ± 2 days) compared to placebo group
(7 ± 2 days;P= 0.03). Also, fentanyl (lg/kg/d) requirement was signiﬁcantly less in lidocaine group
(5.4 ± 2.9 on 1st postoperative day and 4.1 ± 2.6 on 2nd postoperative day) compared to placebo
group (14.4 ± 2.5 on 1st postoperative day and 12.6 ± 3.3 on 2nd postoperative day). Moreover,
return of bowel function was earlier in lidocaine group compared to placebo group (19 ± 6.2 h vs.
23 ± 3.65 h respectively).
Conclusion: Intravenous lidocaine infusion, started preoperatively and continued for 6 h postoper-
atively, attenuated stress response to major abdominal pediatric surgery. It also decreased hospital
stay, opioid requirement and hastened return of bowel function.
ª 2013 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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Postoperative pain is a major concern after any surgical inter-
vention especially major abdominal surgery. Pain is associated
with increased duration of hospital stay; and as a component
of inﬂammatory response following surgery; it also leads to de-
lay in bowel movement and development of ileus as a result of
activation of nocireceptors by inﬂammatory mediators [1–3].
For such reasons, control of postoperative pain is a major con-
cern, and traditionally was achieved by administration of opi-
ates. However, opiate administration has its own side effects
and limitations, especially in pediatric group of patients.
Hence, administration of local anesthetics to epidural space
gains its own role. It blunts stress response; provides rapid
mobilization, leads to early extubation with rapid recovery
of bowel function [4]. However, insertion of an epidural cath-
eter carries its own risks especially in pediatric population [5].
Therefore, seeking for alternative and/or adjunct drugs and
techniques should continue specially in the era of fast track
surgery and enhanced recovery programs.
Lidocaine has been shown to have analgesic, antihyperalge-
sic, and anti-inﬂammatory effects when administrated intrave-
nously [6]. Several studies have shown the role of intravenous
lidocaine administration during abdominal surgery in improv-
ing postoperative analgesia, reducing postoperative opioid
requirements, accelerating postoperative recovery of bowel
function, decreasing postoperative fatigue, reducing the dura-
tion of hospitalization, and enhancing acute rehabilitation in
patients undergoing major abdominal surgery [6,7]. However,
all of these studies were carried out in adult population and
were not involving pediatrics’ one. In the current study we
aim at evaluating the role of systemic lidocaine administration
in children undergoing elective major abdominal surgery as re-
gard the length of hospital stay as a primary outcome. Also
studying its effect on hormonal response, opioid requirement
and return of bowel function.
2. Methods
Over a period of 8 months, all patient aged 1–6 years who were
scheduled for elective major abdominal surgery at Mansoura
University children hospital were assessed for eligibility. Pa-
tients with hepatic, cardiac, or renal morbidity, allergy to local
anesthetics, and/or epilepsy were excluded. The study was ap-
proved by the Research Ethics Board (REB). A detailed expla-
nation of the study including the principles and instructions of
PNCA (Parent-/Nurse-Controlled Analgesia) was given to
parents/legal guardians of children; and an informed consentwas signed. All surgical procedures were done by a well-trained
team of pediatric surgeons. All patients received a premedica-
tion in the form of i.v. midazolam and morphine, in a dose of
0.02–0.1 mg/kg respectively 15 min before induction.
Patients were randomly assigned into two groups based on
a computer-generated sequence, which was kept in sealed enve-
lopes. Immediately before surgery, the envelope was opened by
a pharmacist; who has no role in the data collection or analy-
sis. Based on the allocation of patient; a solution was prepared
from saline (placebo group); or lidocaine 15 mg/ml in similarly
looking syringes. Patients, anesthetists, surgeons, and nurses
were completely blinded about the patients’ allocation. Twenty
minutes before induction of anesthesia, patients received i.v.
bolus 0.1 ml/kg followed by i.v. infusion at 0.1 ml/kg/h of
the prepared solution, then throughout surgery and infusion
was continued for 6 h postoperatively.
Heart rate, noninvasive blood pressure, oxygen saturation,
and end tidal carbon dioxide (EtCO2) concentrations weremon-
itored. Induction was performed with thiopental 3–5 mg/kg and
cisatracurium 0.09 mg/kg. Anesthesia was maintained with 2%
sevoﬂurane, air in oxygen (1:1). The target of ventilation is to
maintain an EtCO2 of 4–4.5 kPa. Sevoﬂurane was discontinued
at the start of skin closure. Ketoprofen (2 mg/kg IV) and 15 mg/
kg i.v. paracetamol was used for intraoperative analgesia. All
patients were started on Parent-/Nurse-Controlled Analgesia
(PNCA) by bolus dose 0.5 lg/kg followed by 0.25 lg/kg/h
fentanyl solution, with 30 min lockout interval and a maximum
of four boluses within 6 h, once the peritoneum was closed.
Residual neuromuscular block was reversed with neostigmine
50 lg/kg and atropine 20 lg/kg at the end of surgery.
Blood samples were withdrawn preoperatively, and at
10 min after start of infusion, 5 min after intubation and
10 min after extubation for assay of serum cortisol level. Also
serum level of lidocaine was checked at 10 min after start of
infusion, 10 min after extubation and 4 h after extubation.
As regard assessment of cortisol level, all samples were centri-
fuged immediately and kept at 60 C; and all samples were
analyzed using radioimmunoassay technique (LI4003K,
Adaltis, Italy). However, the lidocaine level was assessed quan-
titatively (The TDx/TDxFLx; Abbot Diagnostic, USA [8])
immediately because of possibility of toxicity, by a biochemist
who was completely uninvolved in the study and was in-
structed only to disclose the results if the toxic level was
reached in any given sample, otherwise all the results should
be kept conﬁdential till the study end.
Patients were transferred to postanesthetic care unit
(PACU), and assessed for severity of postoperative pain every
10 min by the trained nurse, using FLACC scale (Face, Legs,
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scale based on 5 items and each item is graded from 0 to 2 [9].
Patients were allowed to leave PACU to ward when they
achievemodiﬁedAldrete Score of ten [10]. Furthermore postop-
erative pain was assessed regularly at 2, 6, 12, 24, 36, and 48 h. in
the ward using the same FLACC scale. Also patients were as-
sessed for degree of sedation using modiﬁed Ramsay sedation
scale [11].
Ketoprofen at a dose of 2 mg/kg IV and. Paracetamol at a
dose of 15 mg/kg i.v was used every 8 h postoperatively for
48 h. The lockout interval of the PNCA was decreased to
15 min, when FLACC scale reaches more than 3, return it to
30 min if modiﬁed Ramsay sedation scale rises more than 4;
and the total opioid requirement was documented. A well-
trained nursing team was responsible for assessment of return
of bowel function by auscultation, starting 6 h postoperatively,
and every 2 h later. Furthermore the nursing team was in-
structed to assess the ability of patients to tolerate oral intake,
and to report if any intolerance happens. All the patients
started to ambulate on the ﬁrst postoperative day with guid-
ance, and assistance of the physiotherapist. The physiotherapy
team was responsible for assessment of patients’ activity based
on a standardized hospital protocol. Seizures were reported if
happen. Children were allowed to leave the hospital once they
are able to tolerate light diet, pain free and/or controlled pain
with oral analgesics; and when they can ambulate unaided.
3. Statistical analysis
Data were tested for normality using the Kolmogorov–
Smirnov test. Serial changes in cortisol were analyzed withAssessed for eligib
Randomiz
Placebo group (group P)
n = 40
Discontinued n = 0
Analyzed n = 40
Figure 1 Studrepeated-measures analysis of variance, and Bonferroni correc-
tion was used to set a more stringent P value. Student’s t-test
and the Mann–Whitney U-test were used for comparisons be-
tween and within groups. Chi-square test was used for qualita-
tive data. Data were expressed as mean ± standard deviation
or frequency (%), or medians with interquartile ranges. Data
analysis was done using SPSS 16.0 software (SPSS Inc., Chi-
cago, IL, USA). P< 0.05 was considered as statistically
signiﬁcant.
A priori power analysis, assuming mean hospital stay after
major pediatric abdominal surgeries was 7 ± 2 days, showed
that 40 patients in each group were needed to detect day and
half less in hospital stay, with a power of 90%.
4. Results
All the patients completed the study successfully with no drop-
outs (Fig. 1). No signiﬁcant difference was observed in baseline
characteristics between the two groups. Type of surgery was
similar between the groups, with no signiﬁcant difference in
duration of surgery (96 ± 11.6 vs. 98 ± 13.2; P= 0.35)
(Table 1).
Basal serum cortisol concentrations in both groups were
similar (27.8 ± 7.23 vs. 29.4 ± 8.34 lg/dl; P= 0.23). Placebo
group showed signiﬁcantly greater plasma cortisol concentra-
tions 10 min after start of infusion, 5 min after intubation
and 10 min after extubation (P = 0.001, 0.002, 0.002 respec-
tively) compared with lidocaine group and these concentra-
tions were also higher than the preoperative values (Fig. 2).
There was a signiﬁcant decrease in daily fentanyl consump-
tion in the lidocaine group when compared with placebo groupility (n=83)
Excluded (n= 3)
hepatic insufficiency (n=2 )
Declined to participate (n=1)
ed (n=80)
Lidocaine group (group L)
n = 40
Discontinued n = 0
Analyzed n = 40
y ﬂowchart.
Figure 3 Postoperative FLACC scale in both groups, PACU;
Postanesthetic care unit, P; Placebo group, L; Lidocaine group,
FLACC; Face, Legs, Activity, Cry, Consolability Scale.
Table 1 Demographic data, duration of surgery and type of surgery.
Variable Placebo group Lidocaine group P value
Age (year) 3.7 (2–5) 3.5 (1.5–5) 0.21
Weight (kg) 17 ± 6.1 16 ± 5.2 0.55
Sex
Male 24 (60%) 23 (57.5%) 0.43
Female 16 (40%) 17 (42.5 %) 0.54
Duration of surgery (min) 96 ± 11.6 98 ± 13.2 0.35
Type of Surgery
Fundoplication 18 (45%) 18 (45%)
Splenectomy 8 (20%) 7 (17.5%)
Megacolon 8 (20%) 7 (17.5%)
Othera 6 (15%) 8 (20%)
Data values are mean ± standard deviation, or median (range) or number (%).
a Intestinal malrotation, neuroblastoma.
Figure 2 Perioperative serum cortisol (lg/dl), \Signiﬁcant when
compared with Placebo group.
228 A. El-Deeb et al.(5.4 ± 2.9, 4.1 ± 2.6 vs. 14.4 ± 2.5, 12.6 ± 3.3 lg/kg/d on 1st
and 2nd postoperative day respectively). FLACC scale did not
show any signiﬁcant difference between the groups (Fig. 3).However, Sedation score did not differ signiﬁcantly between
the two groups (Table 2). Furthermore, the return of bowel
function was earlier in the lidocaine group. And more interest-
ingly the length of hospital stay was also signiﬁcantly less in
the lidocaine group (7 ± 2 vs. 5 ± 2; P= 0.03). Toxic plasma
lidocaine level (5 lg/ml) was not reached, and no serious lido-
caine related side effects was reported (Fig. 4).
5. Discussion
In the era of modern enhanced recovery programs aiming at
decrease the length of hospital stay, the issue of pain control
is of outmost importance [12]. In pediatrics, pain control is
mainly achieved by opiate administration. A well-known side
effect of which, is the delayed recovery of bowel function
[13], and hence increase in hospital stay. This study showed
that the perioperative intravenous administration of lidocaine
in pediatrics undergoing elective major abdominal surgery was
associated with decrease in dose of opiates and resulted in
early return of bowel function with signiﬁcant shortening of
hospital stay.
To best of our knowledge based on a Medline search no
previous studies dealt with lidocaine infusion in the periopera-
tive period of major abdominal surgery in pediatric popula-
tion. However, this topic was extensively studied in adult
population. Intravenous lidocaine infusion decreases postoper-
ative pain intensity in adults undergoing abdominal surgery
[14]. It leads to early return of the bowel function, and shorten
duration of hospital stay [1]. Also it has been suggested that
stress hormones released as consequence for surgical trauma;
can be used as an adjunctive method to assess the analgesic
efﬁcacy [15,16] .
The present study showed that a perioperative intravenous
infusion of lidocaine attenuated the hormonal responses to tra-
cheal intubation and surgical trauma. In a study carried on
healthy volunteers; Dirks et al. found that lidocaine infusion
inhibits the sympathetic response associated with tracheal
stimulation and they assumed that effect was due to an in-
creased threshold for airway stimulation, central inhibition
of sympathetic transmission, and direct depression of cardio-
vascular responses [17]. A more recent study by El-Tahan
et al., carried on pregnant women undergoing cesarean deliv-
Table 2 Postoperative data.
Variable Placebo group Lidocaine group P value
Postoperative fentanyl (lg/kg/d)
1st day 14.4 ± 2.5 5.4 ± 2.9* 0.03
2nd day 12.6 ± 3.3 0.04
Postoperative sedation score
1st day 1 (1–2) 4.1 ± 2.6* 0.33
2nd day 1 (1–1) 1 (1–2) 0.34
Length of hospital stay (days) 7 ± 2 5 ± 2* 0.03
Return of bowel function (h) 23 ± 3.6 19 ± 6.2* 0.05
Data values are presented as means ± SD or median (range).
* P< 0.05 signiﬁcant compared with the placebo group.
Figure 4 Perioperative serum lidocaine in group L (lg/ml).
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with signiﬁcant decrease in neuroendocrine response to surgi-
cal trauma [18].
We showed that lidocaine infusion was associated with ear-
lier return of bowel sounds (23 ± 3.6 vs. 19 ± 6.2;
P= 0.05).In their trial, Herroeder et al. [1] investigated the ef-
fect of intravenous perioperative lidocaine on gastrointestinal
motility following colorectal surgery in adults. They concluded
that lidocaine signiﬁcantly improved gastrointestinal motility.
Moreover, Groudine et al. [19] reported that intravenous lido-
caine resulted in faster return of bowel function in patients
undergoing radical prostatectomy. In a meta-analysis of 8
studies including 320 adult patients; lidocaine infusion was
associated with signiﬁcant decrease in duration of postopera-
tive ileus [14].
Our patients in both groups showed a similar FLACC
score; however, patients receiving lidocaine infusion showed
marked decrease in opiate requirement (14.4 ± 2.5,
12.6 ± 3.3 vs. 5.4 ± 2.9, 4.1 ± 2.6 lg/kg/d on 1st and 2nd
postoperative day, P= 0.03, 0.04 respectively), with no differ-
ence in sedation score between the groups. Koppert et al.
[20]showed that perioperative lidocaine administration reduces
pain during major abdominal surgery suggesting that IV lido-
caine has a true preventive analgesic activity. Lauwick et al.
[21] demonstrated that lidocaine infusion decreases postopera-
tive fentanyl requirement in patients undergoing laparoscopic
cholecystectomy. In another research on patients undergoing
laparoscopic cholecystectomy, there was a signiﬁcant improve-
ment of post-operative analgesia and reduced intraoperative
and post-operative opioid requirements in patients receiving
lidocaine infusion [22].
The main interesting ﬁnding of our study is that lidocaine
infusion is associated with signiﬁcant shortening of hospitalstay by almost 2 days (5 ± 2 vs. 7 ± 2; P= 0.03). We assume
that shortening of hospital stay was due to effect of lidocaine
infusion on neuroendocrine response to surgical trauma by
inhibiting the sympathetic activation, and suppression of cor-
tisol release. Furthermore, it was associated with decrease in
opiate requirements, which is well known by its effect on pro-
longation of postoperative ileus. Opioid consumption in the
lidocaine group was signiﬁcantly less than that in the placebo
group. This could be attributed to inhibition of chemonocire-
ceptors by perioperative lidocaine infusion and hence decrease
in sensory neural input which leads to central antihyperalgesic
effect and decrease consumption of analgesics postoperatively.
It is worth to note that effect of lidocaine is associated with
surgeries accompanied with considerable tissue trauma such
as laparotomies [20]. In a recent meta-analysis of 29 studies
including 1752 patients, the authors demonstrated that lido-
caine infusion was associated with a signiﬁcant decrease in
hospital stay with no effect on the hospital mortality [6].
One of the main limitations of this study is that, its power
calculation was based on size effect gained from similar studies
in adult population, which has different neuronal and hor-
monal responses to major abdominal surgery. We recommend
further studies to evaluate the effect of lidocaine infusion in
pediatrics, based on our study as a pilot one. Other limitations,
is that we did not measure the cytokines’ blood levels as a mar-
ker of inﬂammatory response due to ﬁnancial issues.
6. Conclusion
Preoperative intravenous lidocaine infusion continued for 6 h
postoperatively attenuates the stress response to elective major
abdominal surgery in pediatrics. It is also associated with ear-
lier return of bowel function, decrease in opiate requirements,
and decrease in length of hospital stay.
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